This is a demo store. No orders will be fulfilled.

Ripertamab (anti-CD20) - Primary antibody, specific to MS4A1, Human IgG1

    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • Host species: Human
  • Reactive species: Human
  • Isotype: Human IgG1
  • Conjugation: Unconjugated
In stock
Item Number
Ab182891
Grouped product items
SKU Size
Availability
Price Qty
Ab182891-100μg
100μg
10
$109.90
Ab182891-1mg
1mg
4
$519.90
Ab182891-5mg
5mg
1
$1,399.90
Ab182891-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,239.90

Purity>95% (SDS-PAGE&SEC); Endotoxin Level < 0.01EU/μg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

Basic Description

Product Name Ripertamab (anti-CD20) - Primary antibody, specific to MS4A1, Human IgG1
Synonyms APY antibody | ATOPY antibody | B lymphocyte antigen CD20 antibody | B Lymphocyte Cell Surface Antigen B1 antibody | B-lymphocyte antigen CD20 antibody | B-lymphocyte cell-surface antigen B1 antibody | B-lymphocyte surface antigen B1 antibody | B1 antibod
Specifications & Purity Carrier Free, Recombinant, ExactAb™, Low Endotoxin, Azide Free, Validated, Animal Free, ≥95%(SDS-PAGE&SEC-HPLC), See COA
Host species Human
Specificity MS4A1
Conjugation Unconjugated
Grade Animal Free, Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Product Description

Ripertamab (anti-CD20) is a recombinant, human-mouse chimeric anti-CD20 IgG1κ mAb. Ripertamab (anti-CD20) can be used for the research of hematological malignancies, including non-Hodgkin’s lymphoma (NHL).
Purity>95% (SDS-PAGE&SEC)
Endotoxin Level < 0.01EU/μg

Product Properties

Isotype Human IgG1
Light Chain Type kappa
SDS-PAGE 145 kDa
Purification Method Protein A purified
Shape Liquid
Concentration See COA
Storage Temp Store at -80°C,Avoid repeated freezing and thawing
Shipped In Ice chest + Ice pads
Stability And Storage Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
CAS 2249927-04-4

Associated Targets(Human)

MS4A1 Tclin B-lymphocyte antigen CD20 (0 Activities)
Activity Type Activity Value -log(M) Mechanism of Action Activity Reference Publications (PubMed IDs)

Mechanisms of Action

Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References

Images

Ripertamab (anti-CD20) (Ab182891) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD20 with Ripertamab (anti-CD20) (Ab182891) conjugated with biotin (right panel) compared with Human IgG (Biotin) (Ab180314) - Isotype Control (left panel) and detected with SA-PE (rp156150).

Ripertamab (anti-CD20) (Ab182891) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD20 (red) with Ripertamab (anti-CD20) (Ab182891) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, Human IgG (Biotin) (Ab180314). Black - Unlabelled control, cells without incubation with primary antibody.

Ripertamab (anti-CD20) (Ab182891) - SEC
The purity of Ripertamab (anti-CD20) (Ab182891) is more than 95% verified by HPLC.

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Find and download the COA for your product by matching the lot number on the packaging.

3 results found

Lot Number Certificate Type Date Item
ZJ24F0708665 Certificate of Analysis Jul 24, 2024 Ab182891
ZJ24F0708664 Certificate of Analysis Jul 24, 2024 Ab182891
ZJ24F0708663 Certificate of Analysis Jul 24, 2024 Ab182891

Alternative Products

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.